An update on neuropsychiatric adverse effects with second-generation integrase inhibitors and nonnucleoside reverse transcriptase inhibitors.

Author: SennekerTessa, TsengAlice

Paper Details 
Original Abstract of the Article :
Neuropsychiatric adverse effects (NPAE) associated with integrase strand transfer inhibitors (INSTIs) and nonnucleoside reverse transcriptase inhibitors (NNRTIs) are a growing concern, with higher rates in the real-world compared to phase III trials. This paper reviews the incidence, risk factors, a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/34475342

データ提供:米国国立医学図書館(NLM)

Neuropsychiatric Adverse Effects: Navigating the Complexities of HIV Treatment

Treating HIV involves navigating a complex landscape of medications, each with its own unique effects and potential side effects. This research sheds light on a specific aspect of HIV treatment: the neuropsychiatric adverse effects (NPAE) associated with certain classes of drugs.

The study examines the incidence, risk factors, and management of NPAE associated with integrase strand transfer inhibitors (INSTIs) and nonnucleoside reverse transcriptase inhibitors (NNRTIs). The researchers discovered that the real-world incidence of NPAE is higher than what was observed in phase III trials. This finding is like uncovering a hidden oasis in the desert of clinical research, revealing a previously unknown aspect of HIV treatment.

Understanding and Managing Neuropsychiatric Adverse Effects

The study's findings underscore the importance of understanding and managing NPAE associated with HIV treatment. This knowledge can help healthcare providers develop more personalized and effective treatment plans, ultimately improving the quality of life for patients living with HIV.

Living with HIV: Navigating the Landscape of Treatment

This research provides valuable insights for individuals living with HIV. It highlights the importance of being aware of potential side effects associated with medications and communicating openly with healthcare providers about any concerns. This approach is akin to a wise camel navigating a complex desert landscape, ensuring the safe and successful journey through HIV treatment.

Dr. Camel's Conclusion

This study underscores the complex nature of HIV treatment and the importance of careful monitoring for neuropsychiatric adverse effects. It's a reminder that the desert of HIV treatment is full of surprises, and it's crucial to stay vigilant and adapt to the changing landscape of medication and side effects.

Date :
  1. Date Completed 2021-10-22
  2. Date Revised 2023-09-03
Further Info :

Pubmed ID

34475342

DOI: Digital Object Identifier

01222929-202111000-00006

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.